Winje Brita Askeland, Kvestad Ingrid, Krishnamachari Srinivasan, Manji Karim, Taneja Sunita, Bellinger David C, Bhandari Nita, Bisht Shruti, Darling Anne Marie, Duggan Christopher P, Fawzi Wafaie, Hysing Mari, Kumar Tivendra, Kurpad Anura V, Sudfeld Christopher R, Svensen Erling, Thomas Susan, Strand Tor A
Department of Vaccine Preventable Diseases, Norwegian Institute of Public Health, Oslo, Norway.
Regional Centre for Child and Youth Mental Health and Child Welfare, Uni Research Health, Bergen, Norway.
BMJ Open. 2018 Feb 22;8(2):e018962. doi: 10.1136/bmjopen-2017-018962.
As many as 250 million children under the age of 5 may not be reaching their full developmental potential partly due to poor nutrition during pregnancy and the first 2 years of life. Micronutrients, including vitamin B, are important for the development of brain structure and function; however, the timing, duration and severity of deficiencies may alter the impact on functional development outcomes. Consequently, to fully explore the effect of vitamin B on cognitive function, it is crucial to measure neurodevelopment at different ages, in different populations and with vitamin B supplementation at different times during the critical periods of neurodevelopment.
In this project, we follow up children from four recently completed randomised placebo-controlled trials of oral vitamin B supplementation, two in India and two in Tanzania, to explore the long-term effects on neurodevelopmental outcomes and growth. All the included trials provided at least two recommended dietary allowances of oral vitamin B daily for at least 6 months. Vitamin B was supplemented either during pregnancy, early infancy or early childhood. Primary outcomes are neurodevelopmental status, cognitive function and growth later in childhood. We apply validated and culturally appropriate instruments to identify relevant developmental outcomes. All statistical analyses will be done according to intention-to-treat principles. The project provides an excellent opportunity to examine the effect of vitamin B supplementation in different periods during early life and measure the outcomes later in childhood.
The study has received ethical approvals from all relevant authorities in Norway, USA, Tanzania and India and complies fully with ethical principles for medical research. Results will be presented at national and international research and policy meetings and published in peer-reviewed scientific journals, preferably open access.
NCT00641862 (Bangalore); NCT00717730, updated CTRI/2016/11/007494 (Delhi); NCT00197548 and NCT00421668 (Dar es Salaam).
多达2.5亿5岁以下儿童可能无法充分发挥其发育潜力,部分原因是孕期及生命最初两年营养状况不佳。包括维生素B在内的微量营养素对脑结构和功能的发育很重要;然而,缺乏的时间、持续时间和严重程度可能会改变对功能发育结果的影响。因此,为全面探究维生素B对认知功能的影响,在不同年龄、不同人群中以及在神经发育关键时期的不同时间补充维生素B来测量神经发育至关重要。
在本项目中,我们对来自四项近期完成的口服维生素B补充剂随机安慰剂对照试验的儿童进行随访,其中两项在印度,两项在坦桑尼亚,以探究其对神经发育结果和生长的长期影响。所有纳入试验均每日提供至少两份口服维生素B的推荐膳食摄入量,持续至少6个月。维生素B在孕期、婴儿早期或儿童早期进行补充。主要结局为儿童期后期的神经发育状况、认知功能和生长情况。我们应用经过验证且符合文化背景的工具来确定相关发育结果。所有统计分析将根据意向性分析原则进行。该项目为研究生命早期不同时期补充维生素B的效果以及测量儿童期后期的结局提供了绝佳机会。
该研究已获得挪威、美国、坦桑尼亚和印度所有相关当局的伦理批准,并完全符合医学研究的伦理原则。研究结果将在国内和国际研究及政策会议上公布,并发表在同行评审的科学期刊上,最好是开放获取期刊。
NCT00641862(班加罗尔);NCT00717730,更新后的CTRI/2016/11/007494(德里);NCT00197548和NCT00421668(达累斯萨拉姆)。